SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " ibogaine " 17 found 🔀 AI-powered Shuffle
What is ibogaine, and what does it treat?
Psychedelic drugs, once pushed to the fringes of medicine, are gaining serious attention within the Trump administration as potential treatment options for people with certain mental health conditions. And they could be getting closer to receiving approval from the US Food and Drug Administration.
Navy Veteran Creates App to Track Mental Health Changes From Psychedelics
After a former Navy SEAL struggled to find help, he turned to ibogaine. Now, he wants to encourage others.
Trump, ibogaine and the science behind the psychedelics boom in the U.S.
Tracing how psychedelics have undergone a revival in the U.S. and what the White House’s new psychedelic push means for research
Ibogaine Hype Is Outpacing the Science
The hype surrounding the psychedelic drug ibogaine reached a fever pitch earlier this month, when President Donald Trump talked up its potential at a White House event promoting increased access to psychedelics. Ibogaine, which comes from the root of a West African shrub, has long been used for ceremonial and spiritual purposes. Now, for the first time, the Food and Drug Administration will allow a clinical trial of the drug.
What is ibogaine? FDA to fast-track review of drugs for mental health
Could ibogaine, a psychedelic drug, improve Americans' mental health? Some Coloradans says yes
Ibogaine is drawing new interest from the Trump administration. Here’s what to know about the psychedelic
Psychedelic drugs, once pushed to the fringes of medicine, are gaining serious attention within the Trump administration as potential treatment options for people with certain mental health conditions. And they could soon be closer to receiving approval from the US Food and Drug Administration.
Trump’s order on psychedelics could have far-reaching science consequences
A new executive order could make it easier for researchers studying how psychedelic drugs like psilocybin, LSD and ibogaine may be useful in medicine
Trump signs order fast tracking review of psychedelics for mental health disorders
President endorses psilocybin and ibogaine: "Can I have some, please?"
Trump is savaging allies who criticize the Iran war. But he’s treating Joe Rogan very differently
The way Joe Rogan tells it, about all President Donald Trump needed before he fast-tracked research into therapeutic uses for certain psychedelic treatments like Ibogaine was a text from a podcaster.
Trump signs order to hasten review of psychedelics
Ibogaine and other psychedelics remain banned under the federal government's most restrictive category for illegal, high-risk drugs. But the administration is taking steps to ease restrictions and spur research on using the drugs for medical purposes, including conditions like severe depression.
Trump accelerates research on psychedelic treatments and asks, ‘Can I have some?’
President Donald Trump on Saturday signed an executive order aimed at encouraging expanded research into ibogaine and other psychedelic drugs, part of a broader push to explore emerging mental health treatments.
Trump signs order to speed up review of psychedelic drugs for mental health treatment
The order eases restrictions on psychedelic drugs like ibogaine to spur research on using the them for medical purposes.
Trump signs order to speed review of psychedelics, including the controversial drug ibogaine
President Donald Trump has directed his administration to speed up reviews of certain psychedelic drugs, including ibogaine | WBEN
Trump signs order to speed review of psychedelics, including the controversial drug ibogaine
President Donald Trump has directed his administration to speed up reviews of certain psychedelic drugs, including ibogaine.
Trump signs executive order to research ibogaine, a psychedelic used abroad to treat PTSD
The executive order will open the door for more research into the psychedelic drug ibogaine, sources told CBS News earlier this week.
Trump Signs Order To Accelerate Legal Access To Psychedelics For Patients With Mental Health Conditions
President Donald Trump has signed an executive order aimed at expanding and expediting research on the potential therapeutic benefits of psychedelics, a move aimed at making substances such as psilocybin, ibogaine, LSD and MDMA more readily available to patients in clinical settings. The move will “dramatically accelerate access to new medical research and treatments based […]